Literature DB >> 29202326

Substitution of Fried's performance-based physical frailty criteria with self-report questions.

Linda P M Op Het Veld1, Henrica C W de Vet2, Erik van Rossum3, Gertrudis I J M Kempen4, Sander M J van Kuijk5, Anna J H M Beurskens6.   

Abstract

OBJECTIVE: To identify self-report questions that can substitute Fried's performance-based frailty measures for use in large-scale studies and daily practice.
METHODS: A cross-sectional study was conducted among community dwelling older people (65+). Based on a literature search and interviews with older people and experts, 11 questions concerning walk time and 10 on handgrip strength were selected. All participants completed these sets of self-report questions as well as the original Fried criteria (including performance-based tests). Regression analyses were performed to find the questions that best substituted the performance-based tests.
RESULTS: In total, 135 individuals (mean age 73.8±7.0, 58.5% female) in different stages of frailty (non-frail 38.5%, pre-frail 40.7%, frail 20.7%) were included. Regression analyses revealed four questions for walk time and two for handgrip strength. Cut-off values of three for walk time (range 0-5) and one for handgrip strength (range 0-3) seem most optimal. This resulted in a sensitivity of 69.2%, 86.1% specificity and 79.4% agreement for walk time and a sensitivity of 73.2%, 71.3% specificity and 71.9% agreement for handgrip strength. The comparison of frailty stages using frailty criteria including the performance-based measures and scores based solely on self-report questions, resulted in an observed agreement of 71.1% (kappa value=0.55).
CONCLUSIONS: Considering the agreement between the questions and the performance-based tests, these two sets of questions might be used in settings where the performance-based tests of walk time and handgrip strength are unfeasible, such as in daily practice and large-scale research.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Frailty; Fried frailty phenotype; Performance-based measure; Self-report question

Mesh:

Year:  2017        PMID: 29202326     DOI: 10.1016/j.archger.2017.11.009

Source DB:  PubMed          Journal:  Arch Gerontol Geriatr        ISSN: 0167-4943            Impact factor:   3.250


  11 in total

1.  Clinical and cost-effectiveness of a personalised health promotion intervention enabling independence in older people with mild frailty ('HomeHealth') compared to treatment as usual: study protocol for a randomised controlled trial.

Authors:  Rachael Frost; Christina Avgerinou; Claire Goodman; Andrew Clegg; Jane Hopkins; Rebecca L Gould; Benjamin Gardner; Louise Marston; Rachael Hunter; Jill Manthorpe; Claudia Cooper; Dawn A Skelton; Vari M Drennan; Pip Logan; Kate Walters
Journal:  BMC Geriatr       Date:  2022-06-04       Impact factor: 4.070

2.  The value of screening for cognition, depression, and frailty in patients referred for TAVI.

Authors:  Maisha M Khan; Krista L Lanctôt; Stephen E Fremes; Harindra C Wijeysundera; Sam Radhakrishnan; Damien Gallagher; Dov Gandell; Megan C Brenkel; Elias L Hazan; Natalia G Docteur; Nathan Herrmann
Journal:  Clin Interv Aging       Date:  2019-05-08       Impact factor: 4.458

3.  Reliability and validity of the self-reported frailty screening questionnaire in older adults.

Authors:  Yanhong Zhang; Yaxin Zhang; Yun Li; Piu Chan; Lina Ma
Journal:  Ther Adv Chronic Dis       Date:  2020-02-05       Impact factor: 5.091

4.  Validation of replacement questions for slowness and weakness to assess the Fried Phenotype: a cross-sectional study.

Authors:  Michael C J Van der Elst; Birgitte Schoenmakers; Linda P M Op Het Veld; Ellen E De Roeck; Anne Van der Vorst; Jos M G A Schols; Jan De Lepeleire; Gertrudis I J M Kempen
Journal:  Eur Geriatr Med       Date:  2020-06-04       Impact factor: 1.710

5.  Frailty and Determinants of Health Among Older Adults in the United States 2011-2016.

Authors:  Emma L Kurnat-Thoma; Meghan T Murray; Paul Juneau
Journal:  J Aging Health       Date:  2021-09-01

6.  The APPLE Tree programme: Active Prevention in People at risk of dementia through Lifestyle, bEhaviour change and Technology to build REsiliEnce-randomised controlled trial.

Authors:  M Poppe; L Duffy; N L Marchant; J A Barber; R Hunter; N Bass; A M Minihane; K Walters; P Higgs; P Rapaport; I A Lang; S Morgan-Trimmer; J Huntley; Z Walker; H Brodaty; H C Kales; K Ritchie; A Burton; J Wenborn; A Betz; C Cooper
Journal:  Trials       Date:  2022-07-26       Impact factor: 2.728

7.  Screening tools to expedite assessment of frailty in people receiving haemodialysis: a diagnostic accuracy study.

Authors:  Tobia Zanotto; Thomas H Mercer; Marietta L van der Linden; Pelagia Koufaki
Journal:  BMC Geriatr       Date:  2021-07-02       Impact factor: 3.921

8.  Randomized controlled trial to evaluate a prevention program for frail community-dwelling older adults: a D-SCOPE protocol.

Authors:  Deborah Lambotte; Liesbeth De Donder; Ellen E De Roeck; Lieve J Hoeyberghs; Anne van der Vorst; Daan Duppen; Michaël Van der Elst; Bram Fret; Sarah Dury; An-Sofie Smetcoren; Martinus J M Kardol; Sebastiaan Engelborghs; Peter Paul De Deyn; Nico De Witte; Jos M G A Schols; Gertrudis I J M Kempen; G A Rixt Zijlstra; Jan De Lepeleire; Birgitte Schoenmakers; Dominique Verté; Eva Dierckx
Journal:  BMC Geriatr       Date:  2018-08-27       Impact factor: 3.921

9.  Concordances and differences between a unidimensional and multidimensional assessment of frailty: a cross-sectional study.

Authors:  Michael C J Van der Elst; Birgitte Schoenmakers; Linda P M Op Het Veld; Ellen E De Roeck; Anne Van der Vorst; Gertrudis I J M Kempen; Nico De Witte; Jan De Lepeleire; Jos M G A Schols
Journal:  BMC Geriatr       Date:  2019-12-10       Impact factor: 3.921

10.  The type 2 diabetes-specific dementia risk score (DSDRS) is associated with frailty, cognitive and functional status amongst Mexican community-dwelling older adults.

Authors:  Omar Yaxmehen Bello-Chavolla; Carlos Alberto Aguilar-Salinas; José Alberto Avila-Funes
Journal:  BMC Geriatr       Date:  2020-09-22       Impact factor: 3.921

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.